The Latest

THE LATEST Health

THE LATEST THINKING

FDA approves 'glowing tumor' drug to help surgeons identify ovarian cancer cells

Photo by: FOX News

Cytalux (pafolacianince), a drug that binds to ovarian cancer tissue and glows when exposed to fluorescent light, has been approved by the U.S. Food and Drug Administration (FDA) to help surgeons detect ovarian tumors during surgical procedures in patients.

See article

THE LATEST THINKING

The opinions of THE LATEST’s guest contributors are their own.

Searching for TLT's ...

Video Site Tour

The Latest
The Latest

Subscribe to THE LATEST Newsletter.

The Latest
The Latest

Share this story through...

Separate multiple emails with commas. That's not a valid e-mail.